- Home
- Publications
- Publication Search
- Publication Details
Title
Nanodrugs Targeting T Cells in Tumor Therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-25
DOI
10.3389/fimmu.2022.912594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy
- (2022) Kinan Alhallak et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In vivo imaging of nanoparticle-labeled CAR T cells
- (2022) Louise Kiru et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
- (2022) Zhongfeng Ye et al. ACS Biomaterials-Science & Engineering
- Current approaches of nanomedicines in the market and various stage of clinical translation
- (2022) Xiaoting Shan et al. Acta Pharmaceutica Sinica B
- Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy
- (2021) Dongyoon Kim et al. Nano-Micro Letters
- The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
- (2021) Maximilian Haist et al. Cancers
- Nanobiomaterial-based vaccination immunotherapy of cancer
- (2021) Fangmin Chen et al. BIOMATERIALS
- Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells
- (2021) Monika Bednarczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Brush Conformation of Polyethylene Glycol Determines the Stealth Effect of Nanocarriers in the Low Protein Adsorption Regime
- (2021) Mengyi Li et al. NANO LETTERS
- Applications of Nanoparticle-Antibody Conjugates in Immunoassays and Tumor Imaging
- (2021) Xinhao Lin et al. AAPS Journal
- Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion
- (2021) Roel Hammink et al. ACS Applied Materials & Interfaces
- Genome wide DNA methylation landscape reveals glioblastoma’s influence on epigenetic changes in tumor infiltrating CD4+ T cells
- (2021) Marpe Bam et al. Oncotarget
- CAR T-Cell Production Using Nonviral Approaches
- (2021) Viktor Lukjanov et al. Journal of Immunology Research
- Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma
- (2021) Josep Malvehy et al. Journal for ImmunoTherapy of Cancer
- Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
- (2021) Pier Francesco Ferrucci et al. Cancers
- Density of Conjugated Antibody Determines the Extent of Fc Receptor Dependent Capture of Nanoparticles by Liver Sinusoidal Endothelial Cells
- (2021) Cinja Kappel et al. ACS Nano
- Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes
- (2021) Mehdi Barati et al. CANCER GENE THERAPY
- Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization
- (2021) Christopher Groth et al. INTERNATIONAL JOURNAL OF CANCER
- Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the advanced gastric cancer expansion cohort.
- (2021) Kensei Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
- (2021) István Tombácz et al. MOLECULAR THERAPY
- Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation
- (2021) Philipp Boosz et al. Cancers
- Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
- (2021) Tahereh Soltantoyeh et al. Cells
- Advanced Nano-Carriers for Anti-Tumor Drug Loading
- (2021) Jia Xiang et al. Frontiers in Oncology
- Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting
- (2021) David M. Francis et al. BIOMATERIALS
- IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
- (2021) Yingmei Luo et al. BIOMATERIALS
- In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift
- (2021) Azadeh Kheirolomoom et al. BIOMATERIALS
- Highly aminated iron oxide nanoworms for simultaneous manufacturing and labeling of chimeric antigen receptor T cells
- (2021) Wei Zhang et al. JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
- Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells
- (2021) Margaret M. Billingsley et al. NANO LETTERS
- Multifunctional Immunoliposomes Enhance the Immunotherapeutic Effects of PD‐L1 Antibodies against Melanoma by Reprogramming Immunosuppressive Tumor Microenvironment
- (2021) Yu Hei et al. Small
- 421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT
- (2021) Mark Linch et al. Journal for ImmunoTherapy of Cancer
- 547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma
- (2021) Andrew Haydon et al. Journal for ImmunoTherapy of Cancer
- Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles
- (2021) Hiroki Tanaka et al. Pharmaceutics
- A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer
- (2021) Nan Hu et al. Molecular Therapy-Oncolytics
- β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
- (2020) Monika Bednarczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
- (2020) Qianru Yu et al. International Journal of Nanomedicine
- Recent advances in the bioanalytical methods of polyethylene glycols and pegylated pharmaceuticals
- (2020) Zhi Zhang et al. JOURNAL OF SEPARATION SCIENCE
- Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
- (2020) Margaret M. Billingsley et al. NANO LETTERS
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
- (2020) Katharina Reinhard et al. SCIENCE
- Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation
- (2020) Marina Mühlberger et al. Cells
- Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine-Loaded Nanogels
- (2020) Mine Canakci et al. BIOMACROMOLECULES
- Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
- (2020) Connie Kang et al. DRUGS
- Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
- (2020) Yu Hei et al. International Journal of Nanomedicine
- Phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with an anti-PD-1 therapy.
- (2020) Colette Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
- (2020) Manish R. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Self‐Degradable Lipid‐Like Materials Based on “Hydrolysis accelerated by the intra‐Particle Enrichment of Reactant (HyPER)” for Messenger RNA Delivery
- (2020) Hiroki Tanaka et al. ADVANCED FUNCTIONAL MATERIALS
- Imidazole‐based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
- (2020) Xuewei Zhao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial
- (2020) Elizabeth K. Lee et al. GYNECOLOGIC ONCOLOGY
- Silica Nanocapsules with Different Sizes and Physicochemical Properties as Suitable Nanocarriers for Uptake in T-Cells
- (2020) Raweewan Thiramanas et al. International Journal of Nanomedicine
- ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
- (2020) J. A. Kyte et al. Journal of Translational Medicine
- ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
- (2020) J. A. Kyte et al. Journal of Translational Medicine
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
- (2020) Colin G. Buss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
- (2020) Bassel Nazha et al. Frontiers in Oncology
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
- (2020) Raweewan Thiramanas et al. Cells
- Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
- (2020) Ernesto Bockamp et al. Cells
- Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
- (2020) Tilahun Ayane Debele et al. Cancers
- CAR-T cells: Early successes in blood cancer and challenges in solid tumors
- (2020) Hassan Dana et al. Acta Pharmaceutica Sinica B
- Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms
- (2019) Yanheng Wu et al. Nanomaterials
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Targeted delivery of tacrolimus to T cells by pH‐responsive aptamer‐chitosan‐ poly(lactic‐co‐glycolic acid) nanocomplex
- (2019) Atena Mansouri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation
- (2019) Nina Germic et al. CELL DEATH AND DIFFERENTIATION
- Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
- (2019) Quoc-Viet Le et al. AAPS Journal
- Combining Nanomedicine and Immunotherapy
- (2019) Yang Shi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity
- (2019) Hiroshi Yano et al. IMMUNOLOGY
- Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
- (2019) Howard West et al. LANCET ONCOLOGY
- Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy
- (2019) Yu-Xue Zhang et al. NANO LETTERS
- HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
- (2019) Christian Grunwitz et al. OncoImmunology
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
- (2019) Sylvie Bonvalot et al. LANCET ONCOLOGY
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study
- (2019) Neil L Berinstein et al. BLOOD
- Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
- (2019) Ping-Hsiu Wu et al. Cancers
- Overcoming the barrier of CD8+ T cells: Two types of nano-sized carriers for siRNA transport
- (2019) Ilja Tabujew et al. Acta Biomaterialia
- Ultrasmall silica nanoparticles directly ligate the T cell receptor complex
- (2019) Bradley Vis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
- (2018) Shuangjiang Yu et al. ADVANCED MATERIALS
- Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
- (2018) Atlantis Russ et al. BLOOD REVIEWS
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells
- (2018) Urarika Luesakul et al. CARBOHYDRATE POLYMERS
- Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design
- (2018) Eric Pujade-Lauraine et al. Future Oncology
- Protein corona–mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses
- (2018) Limei Shen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
- (2018) Wenquan Ou et al. JOURNAL OF CONTROLLED RELEASE
- Nanoscale artificial antigen presenting cells for cancer immunotherapy
- (2018) Kelly R. Rhodes et al. MOLECULAR IMMUNOLOGY
- Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
- (2018) David R. Wilson et al. Nanomedicine-Nanotechnology Biology and Medicine
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
- (2018) Tinglu Li et al. Oncology Letters
- Programming CAR-T cells to kill cancer
- (2018) Louai Labanieh et al. Nature Biomedical Engineering
- Combining Adhesive Nanostructured Surfaces and Costimulatory Signals to Increase T Cell Activation
- (2018) Judith Guasch et al. NANO LETTERS
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
- (2018) Matthias Bros et al. Frontiers in Immunology
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer
- (2018) Leisha A. Emens et al. JAMA Oncology
- Non-Functionalized Ultrasmall Silica Nanoparticles Directly and Size-Selectively Activate T Cells
- (2018) Bradley Vis et al. ACS Nano
- Impact of Branching on the Solution Behavior and Serum Stability of Starlike Block Copolymers
- (2018) Regina Holm et al. BIOMACROMOLECULES
- Aptamer Based Targeted Drug Delivery Systems: Current Potential and Challenges
- (2018) Fen He et al. CURRENT MEDICINAL CHEMISTRY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoglobulin A: magic bullet or Trojan horse?
- (2017) Marieke H. Heineke et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- (2017) Padmanee Sharma et al. LANCET ONCOLOGY
- Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma
- (2017) Silvia R. Graziani et al. MEDICAL ONCOLOGY
- Integrin-Assisted T-Cell Activation on Nanostructured Hydrogels
- (2017) Judith Guasch et al. NANO LETTERS
- Improving T Cell Expansion with a Soft Touch
- (2017) Lester H. Lambert et al. NANO LETTERS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
- (2017) Jun Ishihara et al. Science Translational Medicine
- Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate
- (2017) Megan E. Muroski et al. Scientific Reports
- Janus nanoparticles for T cell activation: clustering ligands to enhance stimulation
- (2017) Kwahun Lee et al. Journal of Materials Chemistry B
- 1173OMAGRIT, A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF THE RECMAGE-A3 + AS15 CANCER IMMUNOTHERAPEUTIC AS ADJUVANT THERAPY IN PATIENTS WITH RESECTED MAGE-A3-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
- (2017) J.F. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Mechanistic Study of the Conversion of Superoxide to Oxygen and Hydrogen Peroxide in Carbon Nanoparticles
- (2016) Almaz S. Jalilov et al. ACS Applied Materials & Interfaces
- Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy
- (2016) Stefanie U. Frick et al. ACS Nano
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
- (2016) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade
- (2016) Tessa Gargett et al. MOLECULAR THERAPY
- Human immune cell targeting of protein nanoparticles – caveospheres
- (2016) Joshua J. Glass et al. Nanoscale
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates
- (2016) Lisa Gamrad et al. Scientific Reports
- Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
- (2016) Redwan Huq et al. Scientific Reports
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Biomarkers in Cancer Immunotherapy
- (2015) Ton N. Schumacher et al. CANCER CELL
- The Role of TLR4 in Chemotherapy-Driven Metastasis
- (2015) S. Ran CANCER RESEARCH
- Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs – Modern Trojan horses to combat HIV
- (2015) Lakshmi Narashimhan Ramana et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release
- (2015) Oliver Zupke et al. Nanomedicine
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice
- (2013) D. Chinnasamy et al. CANCER RESEARCH
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders
- (2013) Chuang-Wei Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- Fine Tuning and Efficient T Cell Activation with Stimulatory aCD3 Nanoarrays
- (2013) Jovana Matic et al. NANO LETTERS
- First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
- (2012) Neil L Berinstein et al. Journal of Translational Medicine
- Tracking T-cells in vivo with a new nano-sized MRI contrast agent
- (2012) Li Liu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
- (2011) M. O. Butler et al. Science Translational Medicine
- Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
- (2010) Lukas W. Pfannenstiel et al. CELLULAR IMMUNOLOGY
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
- (2008) Alain P. Vicari et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now